Abstract
Nongenetic resistance has recently been described as a major impediment to effective cancer therapy. Nongenetic resistance is challenging to study since it occurs nonuniformly, even in cell lines, and can involve the interplay of multiple survival pathways. Until recently, no technology allowed measurement of large-scale alterations in survival pathways with single-cell resolution. Mass cytometry, a flow-based technique in which the activation of up to 50 proteins can be measured simultaneously in single-cell, now provides the ability to examine nongenetic resistance on the functional level on a cell-by-cell basis. The application of mass cytometry, in combination with new bioinformatic techniques, will allow fundamental questions on nongenetic resistance to be addressed: Is resistance caused by selection of cells with a pre-existing survival phenotype or induction of a survival program? Which survival pathways are necessary for nongenetic resistance and how do they interact? Currently, mass cytometry is being used to investigate the mechanism of nongenetic resistance to TRAIL-induced apoptosis. The approaches being developed to understand resistance to TRAIL will likely be applied to elucidate the mechanisms of nongenetic resistance broadly and in the clinic.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Albeck JG, Burke JM, Aldridge BB et al (2008) Quantitative analysis of pathways controlling extrinsic apoptosis in single cells. Mol Cell 30:11–25. doi:10.1016/j.molcel.2008.02.012
Amir E-AD, Davis KL, Tadmor MD et al (2013) viSNE enables visualization of high dimensional single-cell data and reveals phenotypic heterogeneity of leukemia. Nat Biotechnol 31:545–552. doi:10.1038/nbt.2594
Bendall SC, Simonds EF, Qiu P et al (2011) Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum. Science 332:687–696. doi:10.1126/science.1198704
Brock A, Chang H, Huang S (2009) Non-genetic heterogeneity—a mutation-independent driving force for the somatic evolution of tumours. Nature 10:1–7
Cohen AA, Geva-Zatorsky N, Eden E et al (2008) Dynamic proteomics of individual cancer cells in response to a drug. Science 322:1–6
Dimberg LY, Anderson CK, Camidge R et al (2012) On the TRAIL to successful cancer therapy? Predicting and counteracting resistance against TRAIL-based therapeutics. Oncogene 32:1341–1350. doi:10.1038/onc.2012.164
Duncan JS, Whittle MC, Nakamura K et al (2012) Dynamic reprogramming of the kinome in response to targeted MEK inhibition in triple-negative breast cancer. Cell 149:307–321. doi:10.1016/j.cell.2012.02.053
Flusberg DA, Roux J, Spencer SL, Sorger PK (2013) Cells surviving fractional killing by TRAIL exhibit transient but sustainable resistance and inflammatory phenotypes. Mol Biol Cell. doi:10.1091/mbc.E12-10-0737
Flusberg DA, Sorger PK (2013) Modulating cell-to-cell variability and sensitivity to death ligands by co-drugging. Phys Biol 10:035002. doi:10.1088/1478-3975/10/3/035002
Flynn DFB, Mirotchnick N, Jain M et al (2011) Functional and phylogenetic diversity as predictors of biodiversity–ecosystem-function relationships. Ecology 92:1573–1581
Frese S, Pirnia F, Miescher D et al (2003) PG490-mediated sensitization of lung cancer cells to Apo2L/TRAIL-induced apoptosis requires activation of ERK2. Oncogene 22:5427–5435. doi:10.1038/sj.onc.1206842
Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57–70
Johnstone RW, Frew AJ, Smyth MJ (2008) The TRAIL apoptotic pathway incancer onset, progression and therapy. Nat Rev Cancer 8:782–798. doi: 10.1038/nrc2465
Krutzik PO, Nolan GP (2003) Intracellular phospho-protein staining techniques for flow cytometry: monitoring single cell signaling events. Cytometry 55A:61–70. doi:10.1002/cyto.a.10072
Lee MJ, Ye AS, Gardino AK et al (2012) Sequential application of anticancer drugs enhances cell death by rewiring apoptotic signaling networks. Cell 149:780–794. doi:10.1016/j.cell.2012.03.031
Marusyk A, Almendro V, Polyak K (2012) Intra-tumour heterogeneity: a looking glass for cancer? Nat Publ Group 12:323–334. doi:10.1038/nrc3261
Newsom-Davis T, Prieske S, Walczak H (2009) Is TRAIL the holy grail of cancer therapy? Apoptosis 14:607–623. doi:10.1007/s10495-009-0321-2
Ohtsuka T, Buchsbaum D, Oliver P et al (2003) Synergistic induction of tumor cell apoptosis by death receptor antibody and chemotherapy agent through JNK/p38 and mitochondrial death pathway. Oncogene 22:2034–2044. doi:10.1038/sj.onc.1206290
Okabe S, Tauchi T, Ohyashiki K (2008) Characteristics of dasatinib- and imatinib-resistant chronic myelogenous leukemia cells. Clin Cancer Res 14:6181–6186. doi:10.1158/1078-0432.CCR-08-0461
Oppermann FS, Gnad F, Olsen JV et al (2009) Large-scale proteomics analysis of the human kinome. Mol Cell Proteomics 8:1751–1764. doi:10.1074/mcp.M800588-MCP200
Pisco AO, Brock A, Zhou J et al (2013) Non-Darwinian dynamics in therapy-induced cancer drug resistance. Nat Commun 4:2467. doi:10.1038/ncomms3467
Pujadas E, Feinberg AP (2012) Regulated noise in the epigenetic landscape of development and disease. Cell 148:1123–1131. doi:10.1016/j.cell.2012.02.045
Raser JM (2004) Control of stochasticity in eukaryotic gene expression. Science 304:1811–1814. doi:10.1126/science.1098641
Reya T, Morrison SJ, Clarke MF, Weissman IL (2001) Stem cells, cancer, and cancer stem cells : abstract : nature. Nature 414:105–111. doi:10.1038/35102167
Rodrik-Outmezguine VS, Chandarlapaty S, Pagano NC et al (2011) mTOR kinase inhibition causes feedback-dependent biphasic regulation of AKT signaling. Cancer Discov 1(3)
Ryoo HD, Gorenc T, Steller H (2004) Apoptotic cells can induce compensatory cell proliferation through the JNK and the wingless signaling pathways. Dev Cell 7:491–501. doi:10.1016/j.devcel.2004.08.019
Sachs K (2005) Causal protein-signaling networks derived from multiparameter single-cell data. Science 308:523–529. doi:10.1126/science.1105809
Sah NK, Munshi A, Kurland JF et al (2003) Translation inhibitors sensitize prostate cancer cells to apoptosis induced by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) by activating c-Jun N-terminal kinase. J Biol Chem 278:20593–20602. doi:10.1074/jbc.M211010200
Sharma SV, Lee DY, Li B et al (2010) A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations. Cell 141:69–80. doi:10.1016/j.cell.2010.02.027
Singh DK, Ku C-J, Wichaidit C et al (2010) Patterns of basal signaling heterogeneity can distinguish cellular populations with different drug sensitivities. Mol Syst Biol 6:1–10. doi:10.1038/msb.2010.22
Slack MD, Martinez ED, Wu LF, Altschuler SJ (2008) Characterizing heterogeneous cellular responses to perturbations. Proc Natl Acad Sci 105(49):1–6
Spencer SL, Sorger PK (2011) Measuring and modeling apoptosis in single cells. Cell 144:926–939. doi:10.1016/j.cell.2011.03.002
Spencer SL, Gaudet S, Albeck JG et al (2009) Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosis. Nature 459:428–432. doi:10.1038/nature08012
Waddington CH (1957) The strategy of the genes. A discussion of some aspects of theoretical biology. With an appendix by Kacser H. Allen & Unwinpp, London, pp. ix. 262
Weldon CB, Parker AP, Patten D et al (2004) Sensitization of apoptotically-resistant breast carcinoma cells to TNF and TRAIL by inhibition of p38 mitogen-activated protein kinase signaling. Int J Oncol 24:1473–1480
Yuan TL, Wulf G, Burga L, Cantley LC (2011) Cell-to-cell variability in PI3 K protein level regulates PI3 K-AKT pathway activity in cell populations. Curr Biol 21:173–183. doi:10.1016/j.cub.2010.12.047
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Fienberg, H.G., Nolan, G.P. (2014). Mass Cytometry to Decipher the Mechanism of Nongenetic Drug Resistance in Cancer. In: Fienberg, H., Nolan, G. (eds) High-Dimensional Single Cell Analysis. Current Topics in Microbiology and Immunology, vol 377. Springer, Berlin, Heidelberg. https://doi.org/10.1007/82_2014_365
Download citation
DOI: https://doi.org/10.1007/82_2014_365
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-54826-0
Online ISBN: 978-3-642-54827-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)